|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/14 | |
| A61K 31/519 | |||
| A61P 35/00 |
| (11) | Number of the document | 2925299 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13857873.7 |
| Date of filing the European patent application | 2013-11-26 | |
| (97) | Date of publication of the European application | 2015-10-07 |
| (45) | Date of publication and mention of the grant of the patent | 2018-06-06 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2013/071816 |
| Date | 2013-11-26 |
| (87) | Number | WO 2014/085371 |
| Date | 2014-06-05 |
| (30) | Number | Date | Country code |
| 201261731597 P | 2012-11-30 | US |
| (72) |
CAMPBELL, Gossett, US
HENRIQUEZ, Francisco, US
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | NOVEL PHARMACEUTICAL COMPOSITION |
| NOVEL PHARMACEUTICAL COMPOSITION |